REFERENCES
1. Molyneux DH. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Trans R Soc Trop Med Hyg 2009;103:338-41.
2. Rodriguez JR, Hsieh F, Huang CT, Tsai TJ, Chen C, Cheng MH. Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema. J Surg Oncol 2020;121:25-36.
3. Brorson H, Höijer P. Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment. J Plast Surg Hand Surg 2012;46:410-5.
4. Campanholi LL, Baiocchi JMT, Batista BN, Bergmann A, Fregnani JHTG, Duprat Neto JP. Agreement between optoelectronic volumetry and circumferential girth measurements to diagnose lymphedema in patients submitted to axillary radical lymphadenectomy for treatment of cutaneous melanoma. Lymphat Res Biol 2021; doi: 10.1089/lrb.2017.0081.
5. Douglass J, Graves P, Gordon S. Intrarater reliability of tonometry and bioimpedance spectroscopy to measure tissue compressibility and extracellular fluid in the legs of healthy young people in australia and myanmar. Lymphat Res Biol 2017;15:57-63.
6. diagnosis and treatment of peripheral lymphedema. Consensus document of the international society of lymphology executive committee. Lymphology 1995;28:113-7.
7. Chowdhry M, Rozen WM, Griffiths M. Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema. Gland Surg 2016;5:187-96.
8. Narushima M, Yamamoto T, Ogata F, Yoshimatsu H, Mihara M, Koshima I. Indocyanine green lymphography findings in limb lymphedema. J Reconstr Microsurg 2016;32:72-9.
9. Mitsumori LM, McDonald ES, Wilson GJ, Neligan PC, Minoshima S, Maki JH. MR lymphangiography: how I do it. J Magn Reson Imaging 2015;42:1465-77.
10. Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ. Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol 2016;45:174-9.
11. Lu M, Cohen MH, Rieves D, Pazdur R. FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 2010;85:315-9.
